Stay updated on Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial

Sign up to get notified when there's something new on the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T05:58:26.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-04-23T22:37:43.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about a clinical trial involving Aviptadil for COVID-19 patients at risk of ARDS, while significant background information about the coronavirus pandemic has been removed.
    Difference
    37%
    Check dated 2025-04-16T14:47:39.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.8%
    Check dated 2025-04-09T10:01:48.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:39:50.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-03-11T05:20:52.000Z thumbnail image

Stay in the know with updates to Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page.